Abstract
Purpose: Research on male couples' willingness to use pre-exposure prophylaxis (PrEP) is critically lacking.
Methods: A cross-sectional 2011 Internet survey collected dyadic data from 275 HIV-negative and 58 HIV-discordant male couples to describe 631 HIV-negative partnered mens' willingness to use PrEP and associated couple-level demographic and behavioral factors with multivariate multilevel modeling.
Results: Fifty-three percent were very to extremely likely to use PrEP. Willingness was positively associated with being in a mixed race and behaviorally non-monogamous relationship, and with amyl nitrate use with sex outside the relationship. Willingness was negatively associated with having a college education.
Conclusion: Prevention efforts should educate male couples about the potential benefits of PrEP.
Key words: : HIV prevention, male couples, pre-exposure prophylaxis (PrEP), relationship characteristics, willingness to use
Introduction
Men who have sex with men (MSM) are the only group within the U.S. HIV epidemic which continues to have increased HIV incidence.1 Although HIV risk among MSM was long messaged as driven by multiple casual sex partners, recent evidence shows that between one- and two-thirds of MSM acquire HIV from their main partner (i.e., male couples).2,3 Within the context of HIV-negative and discordant male couples' relationships, increases in HIV risk are attributed to lack of confirmation of both partners' HIV-status (as negative) before condomless anal sex (CAS), higher number of anal sex acts without condoms, more frequent receptive roles, and lack of viral load suppression for the HIV-positive partner.2–8 HIV testing rates within these relationships are also low despite CAS occurring within and outside the relationships.9–12 Partnered MSM also test less frequently because they perceive to be at less risk due to being in a relationship,13 and viewing their main partner as dependable for being trustworthy.10
Pre-exposure prophylaxis (PrEP)—a daily regimen of ART (i.e., Truvada™) taken by those who are HIV-negative to prevent the acquisition of HIV—is one promising biomedical approach to reducing the risk of HIV infection among male couples. Efficacy trials have demonstrated that use of PrEP can reduce the risk of sexual acquisition of HIV infection.14–18 In the multinational iPrEPx study, the safety and efficacy of PrEP in HIV uninfected MSM was established and showed a 44% reduction in incidence of HIV infection.14 Participants in this randomized control trial study who reported using PrEP on 90% or more of the days had a 72.8% reduction in acquisition risk for HIV.14 Since these findings, the U.S. Food and Drug Administration on July 16, 2012, approved Truvada™ for PrEP in combination with safer sex practices to reduce the risk of sexually acquired HIV-infection in adults at high risk, and at the forefront of the targeting of PrEP are high-risk MSM.19 The CDC has also provided guidelines for who may best benefit from PrEP.20 With respect to gay men and other MSM, this includes anyone who: is in an ongoing relationship with an HIV-positive partner (i.e., HIV-discordant male couples); is not in a mutually exclusive monogamous relationship with a partner who recently tested HIV-negative (i.e., HIV-negative male couples with an open relationship or perceived to be monogamous but not); and has had CAS or been diagnosed with a sexually transmitted disease (STD) in the past 6 months.4 However, behavioral research into the factors shaping PrEP willingness, acceptability, and use among male couples is at a nascent stage.
Recent studies have examined attitudes, awareness and willingness to use PrEP among MSM primarily in the U.S.,21–31 with more limited research in Australia, China, France, Thailand, UK, and Canada32–39 through an individual lens, focusing on the individual characteristics of men that shape their desire and ability to use and adhere to PrEP. In general, this body of research has illustrated that MSM, and in particular high-risk MSM (those with multiple sex partners), have positive attitudes towards the adoption of PrEP as a HIV prevention strategy. However, this focus on high-risk MSM has almost ignored male couples' willingness to use PrEP. Studies that provide this type of data are critical to increase PrEP uptake given that two of the Centers for Disease Control and Prevention's (CDC) three recommended PrEP guidelines include those who are in a relationship. By using dyadic data collected in 2011 from a nation-wide U.S. Internet study with 333 gay male couples comprised of 275 HIV-negative and 58 HIV-discordant dyads, we sought to describe 631 HIV-negative partnered mens' willingness to use PrEP, and to assess couple-level demographic and behavioral factors associated with their willingness to use PrEP.
Methods
The Medical College of Wisconsin Institutional Review Board approved the study protocol; methods have been previously described.9,10 Recruitment for this study sample was conducted through Facebook banner advertising: In 2011, advertisements targeting partnered men who reported in their Facebook profile being ≥18 years of age, living in the U.S., interested in men, and being in a relationship, engaged, or married. Banner advertisements briefly described the purpose of the study and included a picture of a male couple. Of a total of 7,994 Facebook users who clicked on an advertisement, 4,056 (51%) answered eligibility questions: 722 (18%), representing both men of 361 MSM couples provided consent and completed the study questionnaire. A total of 631 HIV-negative MSM, representing 275 concordantly negative and 58 HIV-discordant male couples (n=333 dyads), are included in this analysis. Men were eligible to participate if they were ≥18 years of age, lived in the U.S., were in a sexual relationship with another male, and had had oral and/or anal sex with this partner within the previous three months. A partner referral system was embedded in the online survey to enable data collection from both men in the couple. Post-hoc analyses of response consistency in several variables and email addresses were used to verify couples' relationships.
Measures
Participants' willingness to use PrEP was assessed by 1-item with a 5-point Likert-type scale that had response options ranging from 0 (Not at all), 1 (Not very likely), 2 (Somewhat likely), 3 (Very likely) to 4 (Extremely likely). Participants were asked: “How likely are you to take an HIV medication (i.e., Truvada™) daily if the medication helped lower their chances of contracting HIV and consistent condom use is difficult for you?”
Several demographic (e.g., age, race) and relationship characteristics (e.g., relationship length) were assessed, as well as self and primary partner's HIV status, engagement in CAS within the relationship, whether sex had occurred with any casual MSM partners within the previous three months, including CAS with that casual MSM partner. Substance use with sex was assessed categorically by partner type. Other characteristics about this sample have been reported.40–50
Dyadic data from 333 dyads with 631 HIV-negative partnered men were analyzed using Stata v12 (StataCorp, College Station, TX) following recommended guidelines.51,52 Descriptive statistics were calculated. Responses from both partners were used to create couple-level dummy variables to describe and assess demographic and behavioral factors at the couple-level. Independent couple-level variables that were significantly (P<.05) associated with the outcome in the bivariate random-effects regression models were included in a multivariate random-effects multilevel regression model with maximum likelihood estimation. For the final model, backward elimination was used to remove independent variables that remained non-significant until all variables, excluding the pre-determined confounders, remained significant. Age difference between partners, HIV-status, and relationship length were included as potential confounders for the model. The coefficients, standard errors, and statistical significance for the factors in the bivariate and multivariate models are reported.
Results
The average age of men and age difference between partners was 32.2 and 4.9 years, respectively (Table 1). Mean relationship length was approximately 5 years. About one third of couples were nonwhite or mixed race; another third had both partners who earned at least a bachelor's degree. Most partners in the couple reported being employed, having a primary care provider, being in a concordantly HIV-negative relationship, and cohabitating. Most couples also practiced CAS within their relationship. Thirty percent of couples had one or both partners who had sex outside of the relationship. Of these relationships, 63% had one or both partners who had CAS with a casual partner and 53% had one or both partners who had CAS within and outside of their relationship.
Table 1.
Couple-level demographic characteristic | % (n=333 dyads) |
---|---|
Relationship HIV status | |
In HIV-discordant relationship | 17% (58) |
In concordantly HIV-negative relationship | 83% (275) |
Mixed or nonwhite race | 34% (113) |
Education level: Both men had at least a bachelor's degree | 34% (112) |
Employment status: Both men employed | 66% (220) |
Had primary care provider: One or both men reported yes | 61% (203) |
Geographical location: Urban/suburban | 88% (279) |
Mean(SD) | |
Individual age [range: 18–68 years] | 32.2 (10.6) |
Age difference between partners | 4.9 (5.7) |
Relationship length [range: 0.25–35 years] | 4.8 (5.4) |
Cohabitation length [range: 0.08–31.7 years]a | 5.0 (5.7) |
Couple-level sexual behavior | % (n) |
CAS practiced within relationship | 83% (278) |
Sex outside of relationship | 30% (101) |
CAS outside of relationshipb | 63% (64) |
CAS within and out of relationshipb | 53% (54) |
Couple-level substance use with sex—main partner | % (n) |
Party drugsc | 11% (35) |
EDMd | 18% (61) |
Amyl nitrate (e.g., poppers) | 14% (46) |
Marijuana | 30% (101) |
Alcohol | 83% (278) |
Couple-level substance use with sex—casual partner | % (n) |
Party drugsc | 3% (11) |
EDMd | 9% (30) |
Amyl nitrate (e.g., poppers) | 10% (32) |
Marijuana | 8% (28) |
Alcohol | 17% (58) |
With the exception of condomless anal sex (CAS) practiced within the relationship, all reported behaviors include male couples in which one or both men in the relationship self-reported engaging in that behavior (e.g., amyl nitrate with sex—main partner).
Regional data represents the individual men because not all couples reported living together.
Data represents participants who reported living with their main partner for at least one month or longer.
Data reflects among the couples who had one or both partners that had sex outside of their relationship.
Party drugs include ecstasy, ketamine, gamma hydroxybutyrate (GHB), cocaine, and methamphetamine.
EDM, erectile dysfunction medication.
Just over half of HIV-negative partnered men reported being very to extremely likely to use PrEP (53%); the modal response was extremely likely (30%). Men's willingness to use PrEP did not significantly differ by relationship HIV status.
Findings from the bivariate and final multivariate random-effects multilevel regression models are provided in Table 2. The final random-effects multilevel regression model revealed several factors were associated with HIV-negative partnered men's willingness to use PrEP. After controlling for potential confounding factors, willingness to use PrEP was positively associated with being in a mixed race or nonwhite couple, behaviorally non-monogamous relationship, and/or one or both partners having used amyl nitrates with sex outside their relationship. Willingness to use PrEP was negatively associated with being in a relationship with both partners having at least a bachelor's degree.
Table 2.
Bivariate Models | Final multivariate model | |
---|---|---|
Individual-level demographic | β(SE) | β(SE) |
Age | −0.01 (0.01) | |
Education: bachelor's degree or higher | −0.33 (0.11)** | −0.32 (0.11)** |
Hispanic (vs. non-Hispanic) | 0.36 (0.19)* | |
Has health insurance | −0.33 (0.13)** | |
Has primary care provider | −0.20 (0.12) | |
Couple-level demographic | β(SE) | β(SE) |
Relationship length | ||
5 years and less (ref) | 0.23 (0.13)* | 0.23 (0.12) |
Greater than 5 years | ||
Age difference between partners | −0.01 (0.01) | −0.01 (0.01) |
HIV status of relationship | ||
Negative concordant (ref) | −0.27 (0.17) | −0.20 (0.16) |
Discordant | ||
Race | ||
Mixed or nonwhite (ref) | 0.36 (0.12)** | 0.31 (0.12)** |
White | ||
Couple-level sexual behavior | β(SE) | β(SE) |
CAS practiced within relationship | 0.24 (0.16) | |
Sex outside of relationship | ||
One or both men reported “Yes” (ref) | 0.36 (0.12)** | 0.32 (0.14)* |
Both partners reported “No” | ||
CAS with casual MSM partner | ||
One or both men reported “Yes” (ref) | −0.28 (0.22) | |
Both partners reported “No” | ||
CAS with both partner types | ||
One or both men reported “Yes” (ref) | 0.33 (0.15)* | |
Both partners reported “No” | ||
Amyl nitrate use with sex within relationship | ||
One or both men reported “Yes” (ref) | 0.20 (0.17) | |
Both partners reported “No” | ||
Amyl nitrate use with sex outside relationship | ||
One or both men reported “Yes” (ref) | 0.62 (0.19)** | 0.47 (0.21)* |
Both partners reported “No” | ||
EDM use with sex within relationship | ||
One or both men reported “Yes” (ref) | 0.08 (0.15) | |
Both partners reported “No” | ||
EDM use with sex outside relationship | ||
One or both men reported “Yes” (ref) | 0.42 (0.20)* | |
Both partners reported “No” |
Results from final multivariate random-effects multilevel regression model controlled for couples' relationship length, HIV serostatus, and age difference between partners.
626 obs., 333 dyads, χ2 (7)=40.00, P<.001, Log likelihood=−1054.15.
P<.05; **P<.01.
SE, standard error.
Discussion
The present investigation is one of a few studies which assess willingness to use PrEP and associated factors among a U.S. Internet sample of concordant HIV-negative and HIV-discordant gay male couples. More than half of the HIV-negative partnered men were very to extremely likely to use PrEP. In contrast, in a study conducted in San Francisco with concordant HIV-positive and HIV-discordant male couples, Saberi and colleagues (2012) found that the majority of partnered men did not endorse PrEP and some were concerned about the possible increases in risk compensation as a result of PrEP use.53 Although this study did not collect qualitative data to examine the reasons why partnered men might be more or less willing to use PrEP, these findings provide support for partnered men's willingness to use PrEP, particularly among certain subgroups of gay male couples. However, future research studies that collect data from a more representative sample of male couples would provide a greater understanding of men's willingness to use PrEP.
We found that men's willingness to use PrEP increased among those who were in a behaviorally non-monogamous relationship. Given that most couples in this sample practiced CAS within their relationship and for some, also outside of their relationship, this finding is in line with the current guidelines established by the CDC for who may best benefit from using PrEP.20 Under certain circumstances, HIV-negative partnered men may be at substantial risk for HIV acquisition.2,3 Interestingly, there was no difference in PrEP willingness between concordant negative and sero-discordant couples, suggesting that PrEP attitudes may not be sero dependent. Couples may perceive their risk of HIV acquisition differently, and therefore male decision, including their willingness to use PrEP, based on more than the serostatus of themselves and their partner. As shown in previous clinical trial studies, PrEP can help reduce one's risk for acquiring HIV when it is taken consistently and as directed.14–18 Informative prevention messaging is needed to enhance awareness and proper use of PrEP as a risk-reduction strategy for partnered HIV-negative men and male couples in non-monogamous behavioral relationships.
Men's willingness to use PrEP increased among those who were in a nonwhite or mixed race relationship. This finding is significant because U.S. MSM of color are disproportionately affected by HIV/AIDS compared to their white counterparts.1 Educational tools and targeted messaging for this particular population—MSM of color as well as mixed-race male couples—is essential to help advance HIV prevention via PrEP and other methods. Willingness to use PrEP decreased among those with higher levels of education. Although this study did not assess the reasons associated with willingness to use PrEP (i.e., being less willing), men in these relationships may be more skeptical about the effectiveness and/or the side effects of PrEP, thereby emphasizing the need to provide informative messaging about it to address these possible concerns.
Limitations
The use of a cross-sectional study design with a U.S. convenience sample inhibits casual inference and the ability to generalize these results to all Internet-using U.S. male couples or those who do not use Facebook. Although identifying information was not collected, biases of participation, social desirability, and recall may have influenced participants to inaccurately self-report information. Further, other factors could affect male couples' willingness to use of PrEP, including their mental health, presence or history of intimate partner violence, and perceived risk for acquiring HIV. We included responses from all couples, including couples that did not report having outside sex partners; the responses of such couples might have reflected their willingness to use PrEP if their partnership became open, or if they became single in the future. Moreover, these data were collected at a time before PrEP was being discussed in the media and LGBT settings and may not reflect current attitudes toward using PrEP among partnered MSM. Future studies may benefit from the inclusion of these limitations to further assess male couples' willingness to use PrEP and under what circumstances.
HIV-negative partnered men are willing to use PrEP, especially while in a behaviorally non-monogamous and/or mixed race, nonwhite same-sex relationship. As strategies are developed and added to the HIV prevention toolbox for male couples, informative and targeted messaging is needed to promote and enhance the uptake of these new tools, including PrEP. We encourage additional research to better understand how dynamics within and outside of male couples' relationships may encourage or inhibit willingness and actual PrEP use, including their social (e.g., peers) and healthcare environments.
Acknowledgments
Data collection for this manuscript was supported by the center (P30-MH52776; PI J. Kelly) and NRSA (T32-MH19985; PI S. Pinkerton) grants from the National Institute of Mental Health.
Author Disclosure Statement
No competing financial interests exist for either author.
References
- 1.Centers for Disease Control and Prevention (CDC): HIV Among Gay and Bisexual Men. Updated May 21, 2014. Available at http://www.cdc.gov/hiv/risk/gender/msm/facts/index.html Accessed July22, 2014
- 2.Goodreau SM, Carnegie NB, Vittinghoff E, et al. : What drives the US and Peruvian epidemics in men who have sex with men (MSM)? PLoS One 2012;7:e50522. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Sullivan PS, Salazar L, Buchbinder S, Sanchez TH: Estimating the proportion of HIV transmissions from main sex partners among men who have sex with men in five US cities. AIDS 2009;23:1153–1162 [DOI] [PubMed] [Google Scholar]
- 4.Cohen MS, Chen YQ, McCauley M, et al. : Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493–505 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Anglemyer A, Horvath T, Rutherford G: Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. JAMA 2013;310:1619–1620 [DOI] [PubMed] [Google Scholar]
- 6.Anglemyer A, Rutherford GW, Horvath T, et al. : Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. Cochrane Database Syst Rev 2013;4:CD009153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Centers for Disease Control and Prevention (CDC): Prevention Benefits of HIV Treatment [updated April 15, 2013]. Available at http://www.cdc.gov/hiv/prevention/research/tap/ Accessed July22, 2014
- 8.Muessig KE, Smith MK, Powers KA, et al. : Does ART prevent HIV transmission among MSM? AIDS 2012;26:2267–2273 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Mitchell JW, Petroll AE: Patterns of HIV and sexually transmitted infection testing among men who have sex with men couples in the United States. Sex Transm Dis 2012;39:871–876 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Mitchell JW, Horvath KJ: Factors associated with regular HIV testing among a sample of US MSM with HIV-negative main partners. J Acquir Immune Defic Syndr 2013;64:417–423 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Mitchell JW, Petroll AE: HIV testing rates and factors associated with recent HIV testing among male couples. Sex Transm Dis 2012;39:379–381 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Chakravarty D, Hoff CC, Neilands TB, Darbes LA. Rates of testing for HIV in the presence of serodiscordant UAI among HIV-negative gay men in committed relationships. AIDS Behav 2012;16:1944–1948 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Stephenson R, White D, Darbes L, et al. : HIV testing behaviors and perceptions of risk of HIV infection among MSM with main partners. AIDS Behav 2014. [Epub ahead of print] [in press] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Grant RM, Lama JR, Anderson PL, et al. : Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363:2587–2599 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Thigpen MC, Kebaabetswe PM, Paxton LA, et al. : Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med 2012;367:423–434 [DOI] [PubMed] [Google Scholar]
- 16.Baeten JM, Donnell D, Ndase P, et al. : Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012;367:399–410 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. : Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010;329:1168–1174 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Celum C, Baeten JM: Tenofovir-based pre-exposure prophylaxis for HIV prevention: Evolving evidence. Curr Opin Infect Dis 2012;25:51–57 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.U.S. Food and Drug Administration: Truvada for PrEP fact sheet: Ensuring safe and proper use. Available at http://www.fda.gov/downloads/newsevents/newsroom/factsheets/ucm312279.pdf Accessed July22, 2014
- 20.Centers for Disease Control and Prevention (CDC): Pre-Exposure Prophylaxis (PrEP). Updated May 19, 2014. Available at http://www.cdc.gov/hiv/prevention/research/prep/ Accessed July22, 2014
- 21.Stein M, Thurmond P, Bailey G: Willingness to use HIV pre-exposure prophylaxis among opiate users. AIDS Behav 2014;18:1694–1700 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Barash EA, Golden M: Awareness and use of HIV pre-exposure prophylaxis among attendees of a Seattle gay pride event and sexually transmitted disease clinic. AIDS Patient Care STDS. 2010;24:689–691 [DOI] [PubMed] [Google Scholar]
- 23.Mimiaga MJ, Closson EF, Kothary V, Mitty JA: Sexual partnerships and considerations for HIV antiretroviral pre-exposure prophylaxis utilization among high-risk substance using men who have sex with men. Arch Sex Behav 2014;43:99–106 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Mimiaga MJ, Case P, Johnson CV, Safren SA, et al. : Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: Limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr 2009;50:77–83 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Liu AY, Kittredge PV, Vittinghoff E: Limited Knowledge and Use of HIV post- and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr 2008;47:241–247 [PubMed] [Google Scholar]
- 26.Underhill K, Operario D, Mimiaga MJ, Skeer MR, et al. : Implementation science of pre-exposure prophylaxis: Preparing for public use. Curr HIV/AIDS Rep 2010;7:210–219 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Mansergh G, Koblin BA, Sullivan PS: Challenges for HIV pre-exposure prophylaxis among men who have sex with men in the United States. PLoS Med 2012;9:e1001286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Brooks RA, Landovitz RJ, Kaplan RL, Lieber E, et al. : Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: A mixed methods study. AIDS Patient Care STDS 2012;26:87–94 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Rucinski KB, Mensah NP, Sepkowitz KA, Cutler BH, et al. : Knowledge and use of pre-exposure prophylaxis among an online sample of young men who have sex with men in New York City. AIDS Behav 2013;17:2180–2184 [DOI] [PubMed] [Google Scholar]
- 30.Pines HA, Gorbach PM, Weiss RE, Shoptaw S, et al. : Sexual risk trajectories among MSM in the United States: Implications for pre-exposure prophylaxis delivery. J Acquir Immune Defic Syndr 2014;15:579–586 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Juusola JL, Brandeau ML, Owens DK, Bendavid E: The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men. Ann Intern Med 2012;156:541–550 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Leonardi M, Lee E, Tan DH: Awareness of, usage of and willingness to use HIV pre-exposure prophylaxis among men in downtown Toronto, Canada. Int J STD AIDS 2011;22:738–741 [DOI] [PubMed] [Google Scholar]
- 33.Young I, Li J, McDaid L: Awareness and willingness to use HIV pre-exposure prophylaxis amongst gay and bisexual men in Scotland: Implications for biomedical HIV prevention. PLoS One 2013;8:e64038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Holt M, Murphy DA, Callander D, Ellard J, et al. : Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men. Sex Transm Infect 2012;88:258–263 [DOI] [PubMed] [Google Scholar]
- 35.Jackson T, Huang A, Chen H, Gao X, et al. : Cognitive, psychosocial, and sociodemographic predictors of willingness to use HIV pre-exposure prophylaxis among Chinese men who have sex with men. AIDS Behav 2012;16:1853–1861 [DOI] [PubMed] [Google Scholar]
- 36.Aghaizu A, Mercey D, Copas A, Johnson AM, et al. : Who would use PrEP? Factors associated with intention to use among MSM in London: A community survey. Sex Transm Infect 2013;89:207–211 [DOI] [PubMed] [Google Scholar]
- 37.Eisingerich AB, Wheelock A, Gomez GB, Garnett GP, et al. : Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: A multinational study. PLoS One 2012;7:e28238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Sineath RC, Finneran C, Sullivan P, Sanchez T, et al. : Knowledge of and interest in using preexposure prophylaxis for HIV prevention among men who have sex with men in Thailand. J Intl Assoc Provid AIDS Care 2013;12:227–231 [DOI] [PubMed] [Google Scholar]
- 39.Yang D, Chariyalertsak C, Wongthanee A, Kawichai S, et al. : Acceptability of pre-exposure prophylaxis among men who have sex with men and transgender women in Northern Thailand. PLoS One 2013;8:e76650. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Mitchell JW, Sullivan PS: Relationship and demographic factors associated with willingness to use an in-home HIV rapid test (HT) to screen potential sex partners among a US sample of HIV-negative and HIV-discordant male couples. J Acquir Immuno Defic Syndr 2015. [Epub ahead of print] [in press] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Mitchell JW, Sullivan PS: HIV-negative partnered men's attitudes toward using an in-home rapid HIV test and associated factors among a sample of US HIV-negative and HIV-discordant male couples. Sex Transm Dis 2015. [Epub ahead of print] [in press] [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Mitchell JW: Differences in gay male couples' use of drugs and alcohol with sex by relationship HIV status. Am J Mens Health 2014. [Epub ahead of print]: DOI: 10.1177/1557988314559243 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Mitchell JW: Relationship characteristics differ based on use of substances with sex among an urban internet sample of HIV-discordant and HIV-positive male couples. J Urban Health 2014. [Epub ahead of print]: DOI: 10.1007/s11524-014-9926-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Petroll AE, Mitchell JW: Health insurance and disclosure of same-sex sexual behaviors among gay and bisexual men in same-sex relationships. LGBT Health 2015;2:48–54 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Mitchell JW, Boyd C, McCabe S, Stephenson R: A cause for concern: Male couples' sexual agreements and their use of substances with sex. AIDS Behav 2014;18:1401–1411 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Mitchell JW: Aspects of gay male couples' sexual agreements vary by relationship length. AIDS Care 2014;26:1164–1170 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Mitchell JW: Gay male couples' attitudes toward using couples-based voluntary HIV counseling and testing. Arch Sex Behav 2014;43:161–171 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Mitchell JW: Between and within couple-level factors associated with gay male couples' investment in a sexual agreement. AIDS Behav 2014;18:1454–1465 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Mitchell JW: Characteristics and allowed behaviors of gay male couples' sexual agreements. J Sex Res 2014;51:316–328 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Mitchell JW: HIV-negative and HIV-discordant gay male couples' use of HIV risk-reduction strategies: Differences by partner type and couples' HIV-status. AIDS Behav 2013;17:1557–1569 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Rabe-Hesketh S, Skrondal A: Multilevel and Longitudinal Modeling Using Stata. College Station, Texas: Stata Press, 2008 [Google Scholar]
- 52.Kenny D, Kashy D, Cook W: Dyadic Data Analysis. New York: Guilford Press, 2006 [Google Scholar]
- 53.Saberi P, Gamarel KE, Neilands TB, Comfort M, et al. : Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: A mixed methods study. PLoS One 2012;7:e50061. [DOI] [PMC free article] [PubMed] [Google Scholar]